Ask AI

CCO Official Conference Coverage of IAS 2025: The Latest Updates in HIV *

This program outlines important data and highlights from the 13th International AIDS Society (IAS) Conference on HIV Science.

Share

Program Content

Activities

Themes From IAS 2025
Themes From IAS 2025: Emerging Evidence, Innovations, and Global Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2025

3 Capsule Summaries

Activities

ACTG A5391 DO IT
ACTG A5391/DO-IT Trial: Switching to DOR ± TDF vs Continuing INSTI + TAF/FTC in People With Obesity and HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Ulonivirine and Islatravir
Switch to Ulonivirine + Islatravir in Adults With Virologically Suppressed HIV-1: Phase IIb Trial
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Real-world LA CAB + RPV With Viremia in OPERA
Switch to LA CAB + RPV in People With HIV and Detectable Viral Load in OPERA Cohort
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC  in partnership with the International AIDS Society  

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.